subject area of
- A Randomized Trial Comparing Concurrent versus Sequential Radiation and Endocrine Therapy in Early-Stage, Hormone-Responsive Breast Cancer Journal Articles
- American Society of Clinical Oncology Technology Assessment Working Group Update: Use of Aromatase Inhibitors in the Adjuvant Setting Journal Articles
- American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors As Adjuvant Therapy for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Status Report 2004 Journal Articles
- American Society of Clinical Oncology Technology Assessment on the Use of Aromatase Inhibitors as Adjuvant Therapy for Women With Hormone Receptor–Positive Breast Cancer: Status Report 2002 Journal Articles
- American Society of Clinical Oncology Technology Assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004 Journal Articles
- An aromatase inhibitor and tamoxifen decrease plasma levels of o,p′-DDT and its metabolites in Nile tilapia (Oreochromis niloticus) Journal Articles
- Aromatase Inhibitor Exemestane has Antiproliferative Effects on Human Mesothelioma Cells Journal Articles
- Aromatase inhibitors in adjuvant therapy for hormone receptor positive breast cancer: A systematic review Journal Articles
- Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials Journal Articles
- Aromatase inhibitors versus tamoxifen in premenopausal women with oestrogen receptor-positive early-stage breast cancer treated with ovarian suppression: a patient-level meta-analysis of 7030 women from four randomised trials Journal Articles
- Assessment of Quality of Life in MA.17: A Randomized, Placebo-Controlled Trial of Letrozole After 5 Years of Tamoxifen in Postmenopausal Women Journal Articles
- Bone density and structure in healthy postmenopausal women treated with exemestane for the primary prevention of breast cancer: a nested substudy of the MAP.3 randomised controlled trial Journal Articles
- Cancer Treatment–Induced Bone Loss in Breast and Prostate Cancer Journal Articles
- Clinical outcomes of ethnic minority women in MA.17: a trial of letrozole after 5 years of tamoxifen in postmenopausal women with early stage breast cancer Journal Articles
- Cognitive effects of aromatase inhibitor therapy in peripubertal boys Journal Articles
- Competing risks of death in women treated with adjuvant aromatase inhibitors for early breast cancer on NCIC CTG MA.27 Journal Articles
- Cortical and trabecular bone at the radius and tibia in postmenopausal breast cancer patients: A Peripheral Quantitative Computed Tomography (pQCT) study Journal Articles
- Discovery of a new class of cinnamyl-triazole as potent and selective inhibitors of aromatase (cytochrome P450 19A1) Journal Articles
- Discovery of a novel class of aldol-derived 1,2,3-triazoles: Potent and selective inhibitors of human cytochrome P450 19A1 (aromatase) Journal Articles
- Effect of Letrozole Versus Placebo on Bone Mineral Density in Women With Primary Breast Cancer Completing 5 or More Years of Adjuvant Tamoxifen: A Companion Study to NCIC CTG MA.17 Journal Articles
- Effects of cortisol and oestradiol on hepatic 11beta-hydroxysteroid dehydrogenase type 1 and glucocorticoid receptor proteins in late-gestation sheep fetus Journal Articles
- European oncologists' preferences for the management of breast cancer: case presentations and expert commentary Journal Articles
- Exemestane Versus Anastrozole in Postmenopausal Women With Early Breast Cancer: NCIC CTG MA.27—A Randomized Controlled Phase III Trial Journal Articles
- Extending Aromatase-Inhibitor Adjuvant Therapy to 10 Years Journal Articles
- Genetic Polymorphisms in the Long Noncoding RNA MIR2052HG Offer a Pharmacogenomic Basis for the Response of Breast Cancer Patients to Aromatase Inhibitor Therapy Journal Articles
- Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors Journal Articles
- Impact of premenopausal status at breast cancer diagnosis in women entered on the placebo-controlled NCIC CTG MA17 trial of extended adjuvant letrozole Journal Articles
- Investigation of aryl halides as ketone bioisosteres: Refinement of potent and selective inhibitors of human cytochrome P450 19A1 (aromatase) Journal Articles
- Managing Patients on Endocrine Therapy: Focus on Quality-of-Life Issues Journal Articles
- Managing patients on endocrine therapy: Focus on quality-of-life issues Conferences
- Optimal Duration of Extended Adjuvant Endocrine Therapy for Early Breast Cancer; Results of the IDEAL Trial (BOOG 2006-05) Journal Articles
- Osteoporosis therapy and outcomes for postmenopausal patients with hormone receptor–positive breast cancer: NCIC CTG MA.27 Journal Articles
- Patient-Reported Cognitive Impairment Among Women With Early Breast Cancer Randomly Assigned to Endocrine Therapy Alone Versus Chemoendocrine Therapy: Results From TAILORx Journal Articles
- Polyphenolic natural products and natural product–inspired steroidal mimics as aromatase inhibitors Journal Articles
- Primary tumor and patient characteristics in breast cancer as predictors of adjuvant therapy regimen: a regression model Journal Articles
- Quality of Life From Canadian Cancer Trials Group MA.17R: A Randomized Trial of Extending Adjuvant Letrozole to 10 Years Journal Articles
- Reduction in Endometrioma Size with Three Months of Aromatase Inhibition and Progestin Add-Back Journal Articles
- Remission of Macroglobulinemia during Anastrozole Treatment for Breast Cancer Journal Articles
- Screening for Osteoporosis in Postmenopausal Women With Breast Cancer Receiving Aromatase Inhibitors: Less Is More? Journal Articles
- Severe prolonged cholestatic hepatitis caused by exemestane Journal Articles
- Synthesis of α-methylstilbenes using an aqueous Wittig methodology and application toward the development of potent human aromatase inhibitors Journal Articles
- The effects of dietary phytoestrogens on aromatase activity in human endometrial stromal cells Journal Articles
- Towards optimal endocrine therapy for hormone-sensitive breast cancer: Initial versus sequential adjuvant aromatase inhibition Journal Articles